Cargando…
Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease
The development of suitable safe adjuvants to enhance appropriate antigen-driven immune responses remains a challenge. Here we describe the adjuvant properties of a small molecule activator of the integrins αLβ2 and α4β1, named 7HP349, which can be safely delivered systemically independent of antige...
Autores principales: | Lokugamage, Nandadeva, Chowdhury, Imran H., Biediger, Ronald J., Market, Robert V., Khounlo, Sayadeth, Warier, Navin D., Hwang, Shen-An, Actor, Jeffrey K., Woodside, Darren G., Marathi, Upendra, Vanderslice, Peter, Garg, Nisha Jain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426359/ https://www.ncbi.nlm.nih.gov/pubmed/34497271 http://dx.doi.org/10.1038/s41541-021-00378-5 |
Ejemplares similares
-
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1
por: Woodside, Darren G., et al.
Publicado: (2018) -
Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of Trypanosoma cruzi Infection
por: Lokugamage, Nandadeva, et al.
Publicado: (2020) -
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade
por: Hickman, Amber, et al.
Publicado: (2022) -
Experimental Nanovaccine Offers Protection Against Repeat Exposures to Trypanosoma cruzi Through Activation of Polyfunctional T Cell Response
por: Chowdhury, Imran H., et al.
Publicado: (2020) -
TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
por: Gupta, Shivali, et al.
Publicado: (2019)